Search

A study conducted at Sun Yat-sen University in Guangzhou, China, focused on developing a cancer cell membrane camouflaged nanoplatform for tumor inhibition using gelatin-based nanogels. The research aimed to enhance tumor targeting and reduce clearance by the reticuloendothelial system in cancer therapy. By utilizing a biomimetic approach, the nanoplatform showed promising results in achieving homologous targeting to lesion tissue and minimizing side effects of chemotherapy. This study provides a significant strategy for effective targeted therapy and specific carcinoma treatment. [Extracted from the article]

A recent study conducted at the University of Jinan in Guangzhou, China, focused on developing hybrid cell membrane-coated liposomal probes for targeted blood-brain barrier penetration and precise imaging of infiltrative glioblastoma margins. The research aimed to address the challenges posed by the infiltrative nature of glioblastoma margins and the blood-brain barrier in achieving complete tumor removal. The study demonstrated that the hybrid cell membrane-coated indocyanine green (ICG) liposomes showed enhanced blood-brain barrier permeation and improved accuracy in tumor margin detection, potentially facilitating fluorescence-guided precision surgery for glioblastoma. [Extracted from the article]

Researchers from Sun Yat-sen University in Guangzhou, China have developed a biomimetic drug delivery system for the prevention of hepatic ischemia-reperfusion injury (HIRI). The system uses mesenchymal stem cell (MSC) membrane-camouflaged liposomes to target liver injury sites. In a mouse model, the liposomes significantly reduced liver damage and restored liver function using only one-tenth of the dosage typically required for the drug cyclosporine A (CsA). The study suggests that this biomimetic strategy has potential for HIRI intervention. [Extracted from the article]

A recent study conducted by researchers at Southern Medical University in Guangzhou, China, explores the potential of combining cell membrane-targeting photodynamic therapy (PDT) with FSP1 inhibition for ferroptosis-enhanced photodynamic immunotherapy. The researchers developed a photosensitizer called TBzT-CNQi that can induce lipid peroxide accumulation and ferroptosis. By incorporating an FSP1 inhibitor, the researchers were able to activate tumor immunogenic ferroptosis and promote immune responses. The study suggests that this combination therapy holds promise for the treatment of hypoxia tumors. [Extracted from the article]

Researchers at Southern Medical University in Guangzhou, China have conducted a study on brain cancer treatment. The study focused on the blood-brain barrier (BBB), which hinders drug delivery to brain tumors. The researchers investigated whether nanoparticles coated with brain microvascular endothelial cell membranes could target and cross the BBB to deliver drugs to brain tumors. The study found that these nanoparticles effectively targeted brain microvascular endothelial cells and crossed the BBB, accumulating in brain tumors and efficiently killing tumor cells. The research suggests that this strategy has great therapeutic potential for treating brain tumors. [Extracted from the article]

A recent report from the University of Jinan in Guangzhou, China discusses the potential of repurposing the drug cinacalcet as a therapeutic agent for multidrug-resistant Staphylococcus aureus (MRSA) infections. The study found that cinacalcet demonstrated antibacterial and antibiofilm activity against MRSA, with less observed development of bacterial resistance. The drug was found to target IcaR, inhibiting biofilm formation through the negative regulation of IcaADBC. These findings suggest that cinacalcet may have potential as a treatment for MRSA infections and associated biofilms, but further investigation is needed. [Extracted from the article]

A recent report from researchers at the University of Jinan in Guangzhou, China, discusses the development of a new treatment approach for nasopharyngeal carcinoma, a type of cancer. The researchers have created a biomimetic nano erythrocyte that can deliver nitric oxide (NO) gas molecules to tumor sites. When stimulated by near-infrared light, the nanoparticles generate heat for photothermal therapy and release NO, which helps to kill tumors and alleviate tumor hypoxia. This combination strategy shows promise for improving the efficacy of cancer therapy. The research has been peer-reviewed and published in the Journal of Materials Chemistry B. [Extracted from the article]

A study conducted by Guangzhou Medical University in China examined the role of glucose transporter 1 (GLUT1) in the dysfunction of epithelial tight junctions in acute lung injury (ALI). The researchers inhibited GLUT1 in a mouse model of ALI and in cultured epithelial cells, and found that it restored the expression of tight junction proteins and decreased pulmonary inflammation. The study concluded that GLUT1 is responsible for the dysfunction of epithelial tight junctions in the late phase of ALI. This research has been peer-reviewed and published in the European Journal of Pharmacology. [Extracted from the article]

Keywords: Guangzhou; People's Republic of China; Asia; Adult Stem Cells; Cardiology; Cardiomyocyte; Cell Membrane; Cell Membrane Structures; Cellular Structures; Emerging Technologies; Gap Junctions; Glycopeptides; Health and Medicine; Induced Pluripotent Stem Cells; Intercellular Junctions; Nanotechnology; Peptides and Proteins; Stem Cell Research; Supramolecular EN Guangzhou People's Republic of China Asia Adult Stem Cells Cardiology Cardiomyocyte Cell Membrane Cell Membrane Structures Cellular Structures Emerging Technologies Gap Junctions Glycopeptides Health and Medicine Induced Pluripotent Stem Cells Intercellular Junctions Nanotechnology Peptides and Proteins Stem Cell Research Supramolecular 747 747 1 07/31/23 20230801 NES 230801 2023 JUL 31 (NewsRx) -- By a News Reporter-Staff News Editor at Stem Cell Week -- Investigators discuss new findings in Stem Cell Research - Pluripotent Stem Cells. Guangzhou, People's Republic of China, Asia, Adult Stem Cells, Cardiology, Cardiomyocyte, Cell Membrane, Cell Membrane Structures, Cellular Structures, Emerging Technologies, Gap Junctions, Glycopeptides, Health and Medicine, Induced Pluripotent Stem Cells, Intercellular Junctions, Nanotechnology, Peptides and Proteins, Stem Cell Research, Supramolecular. [Extracted from the article]

Keywords: Guangzhou; People's Republic of China; Asia; Bioengineering; Biomimetics; Bionanotechnology; Biotechnology; Cancer; Cell Membrane; Cellular Structures; Drugs and Therapies; Emerging Technologies; Health and Medicine; Immunotherapy; Nanobiotechnology; Nanocomposites; Nanotechnology; Oncology EN Guangzhou People's Republic of China Asia Bioengineering Biomimetics Bionanotechnology Biotechnology Cancer Cell Membrane Cellular Structures Drugs and Therapies Emerging Technologies Health and Medicine Immunotherapy Nanobiotechnology Nanocomposites Nanotechnology Oncology 837 837 1 07/24/23 20230725 NES 230725 2023 JUL 25 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- New research on Cancer is the subject of a report. For more information on this research see: Cancer Immunotherapy Based On Cell Membrane-coated Nanocomposites Augmenting Cgas/sting Activation By Efferocytosis Blockade. [Extracted from the article]

According to the news editors, the research concluded: "Upon two-photon excitation at 730 nm, the nanoparticles were able to identify as well as nearly fully eradicate a melanoma tumor inside a mouse model by synergistic chemotherapy and near-infrared photodynamic therapy." Keywords: Guangzhou; People's Republic of China; Asia; Biotechnology; Cancer; Cell Membrane; Cellular Structures; Chemotherapy; Drugs and Therapies; Emerging Technologies; Health and Medicine; Melanoma; Nanocomposites; Nanoparticles; Nanotechnology; Oncology; Pharmaceuticals; Photodynamic Therapy; Photodynamics; Phototherapy; Therapy EN Guangzhou People's Republic of China Asia Biotechnology Cancer Cell Membrane Cellular Structures Chemotherapy Drugs and Therapies Emerging Technologies Health and Medicine Melanoma Nanocomposites Nanoparticles Nanotechnology Oncology Pharmaceuticals Photodynamic Therapy Photodynamics Phototherapy Therapy 758 758 1 05/15/23 20230516 NES 230516 2023 MAY 16 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- A new study on Oncology - Melanoma is now available. [Extracted from the article]

Keywords: Guangzhou; People's Republic of China; Asia; Cell Membrane; Cellular Structures; Emerging Technologies; Nanobiotechnology; Nanoparticles; Nanotechnology EN Guangzhou People's Republic of China Asia Cell Membrane Cellular Structures Emerging Technologies Nanobiotechnology Nanoparticles Nanotechnology 1231 1231 1 04/10/23 20230414 NES 230414 2023 APR 14 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Researchers detail new data in Nanotechnology - Nanobiotechnology. Guangzhou, People's Republic of China, Asia, Cell Membrane, Cellular Structures, Emerging Technologies, Nanobiotechnology, Nanoparticles, Nanotechnology. [Extracted from the article]

Keywords for this news article include: Guangzhou, People's Republic of China, Asia, Amyloid, Antiinfectives, Antituberculosis Agents, Cell Membrane, Cellular Structures, Drugs and Therapies, Genetics, Health and Medicine, Hydrazines, Immunofluorescence, Intercellular Junctions, Isoniazid, Isoniazid Therapy, Nicotinic Acid Derivatives, Peptides and Proteins, Pharmaceuticals, Proteins, Synapses, National Key Clinical Department. Keywords: Guangzhou; People's Republic of China; Asia; Amyloid; Antiinfectives; Antituberculosis Agents; Cell Membrane; Cellular Structures; Drugs and Therapies; Genetics; Health and Medicine; Hydrazines; Immunofluorescence; Intercellular Junctions; Isoniazid; Isoniazid Therapy; Nicotinic Acid Derivatives; Peptides and Proteins; Pharmaceuticals; Proteins; Synapses EN Guangzhou People's Republic of China Asia Amyloid Antiinfectives Antituberculosis Agents Cell Membrane Cellular Structures Drugs and Therapies Genetics Health and Medicine Hydrazines Immunofluorescence Intercellular Junctions Isoniazid Isoniazid Therapy Nicotinic Acid Derivatives Peptides and Proteins Pharmaceuticals Proteins Synapses 2203 2203 1 03/23/23 20230324 NES 230324 2023 MAR 24 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Research findings on Drugs and Therapies - Nicotinic Acid Derivatives are discussed in a new report. [Extracted from the article]

New Cancer Findings from University of Jinan Discussed (Cell Membrane-camouflaged Dox-loaded ? Guangzhou, People's Republic of China, Asia, Cancer, Cellular Structures, Cell Membrane, Connective Tissue Cells, Drugs and Therapies, Emerging Technologies, Health and Medicine, Immunology, Macrophages, Myeloid Cells, Nanoparticles, Nanosystems, Nanotechnology, Oncology, Phagocytes, Mononuclear Phagocyte System Keywords: Guangzhou; People's Republic of China; Asia; Cancer; Cell Membrane; Cellular Structures; Connective Tissue Cells; Drugs and Therapies; Emerging Technologies; Health and Medicine; Immunology; Macrophages; Mononuclear Phagocyte System; Myeloid Cells; Nanoparticles; Nanosystems; Nanotechnology; Oncology; Phagocytes EN Guangzhou People's Republic of China Asia Cancer Cell Membrane Cellular Structures Connective Tissue Cells Drugs and Therapies Emerging Technologies Health and Medicine Immunology Macrophages Mononuclear Phagocyte System Myeloid Cells Nanoparticles Nanosystems Nanotechnology Oncology Phagocytes 382 382 1 03/24/23 20230224 NES 230224 2023 FEB 21 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Researchers detail new data in Cancer. [Extracted from the article]